Market Access Heard on the pipeline: Access to medications Solving the challenge of access to medication has fuelled many a debate among healthcare stakeholders over the years.
Market Access Mind the gap: What is causing the ongoing ADHD drug shortage... Since late 2022, medications for Attention Deficit/Hyperactivity Disorder, or ADHD, have been in a shortage in the United States and the UK.
Market Access Integrating market access considerations into biopharmaceuti... The biopharmaceutical industry operates at the intersection of health innovation and market viability, where the significance of integrating market access insights into investment decisions
Market Access Overcoming AMR market failure: Three start-up stories Slowly but surely, the world’s antibiotics are becoming less effective as disease-causing bacteria evolve into drug-resistant “superbugs”.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
